From: An alternative approach with a low dose and prolonged chemotherapy for palliative treatment of locally advanced, metastatic or recurrent squamous cell head and neck cancer
Tumor response
At 1st follow-up study (At median of 3.5Â months)
At the end of study (At median of 10.1Â months)
n
%
CR
4
12.5
9
28.1
nCR
2
6.3
PR
17
53.1
7
21.9
SD
6
18.8
3
9.4
PD
11
34.4
DCR
29
90.6
21
65.6
ORR
23
71.9
18
56.3